These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Forskolin, a new positive inotropic agent, and its influence on myocardial electrogenic cation movements. Author: Späh F. Journal: J Cardiovasc Pharmacol; 1984; 6(1):99-106. PubMed ID: 6199620. Abstract: Forskolin exerts concentration-dependent positive inotropic effects in guinea pig isolated papillary muscles; resting potential, overshoot, and upstroke velocity remain unchanged. It markedly potentiates Ca2+-mediated action potentials elicited in partially depolarized myocardial fibers (increases in upstroke velocity, height, and action potential duration) and restores slow-channel-mediated transmembrane Ca2+ influx and contractile force under conditions of external Ca2+ withdrawal or in the presence of the specific Ca2+ antagonist D 600. In partially depolarized ventricular muscle, the potentiation of transmembrane inward Ca2+ current by forskolin is correlated with a reciprocal inhibition of Mg2+-induced electrogenic membrane effects. In this respect, forskolin resembles other Ca2+ influx promoters such as beta-adrenoceptor agonists, histamine, and dibutyryl-cyclic AMP (cAMP). All these agents favor sarcolemmal Ca2+ accumulation through increases in intracellular cAMP and the subsequent formation of Ca2+-binding phosphorylated membrane proteins; Mg2+ ions seem to be displaced by Ca2+. These findings support the concept that the effects of forskolin result from an increase in intracellular cAMP.[Abstract] [Full Text] [Related] [New Search]